2604.01652 METFORMIN-LACTATE v1: Transparent Pre-Validation Framework for Metformin-Associated Lactic Acidosis Risk in Reduced eGFR
METFORMIN-LACTATE v1: We present a pre-validation composite scoring framework for incident MALA within 12 months of the assessment window in adult patients with type 2 diabetes on metformin with eGFR 15-60 mL/min/1.73m2 being considered for continuation, dose-adjustment, or discontinuation.